COMMUNIQUÉS West-GlobeNewswire

Nova Leap Health Corp. to Highlight Record Q2 2025 Results at Planet MicroCap Showcase Toronto
14/10/2025
NOT FOR DISSEMINATION IN THE UNITED STATES OR FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES HALIFAX, Nova Scotia, Oct. 14, 2025 (GLOBE NEWSWIRE) -- NOVA LEAP HEALTH CORP. (TSXV: NLH) (“Nova Leap” or “the Company”), a [...]
Breakthrough in Obesity Solutions: Fuzzle’s Non-Invasive Oral Device Begins FDA Review Process
14/10/2025
Dover, DE, Oct. 14, 2025 (GLOBE NEWSWIRE) -- In a major step forward for obesity solutions, Fuzzle, a pioneering health technology company, announced today that its innovative oral device has officially entered the U.S [...]
EmblemHealth Achieves 4-Star Medicare Rating, Highlighting Sustained Quality Improvements
14/10/2025
Defying national trends in downward Medicare Advantage ratings for not-for-profit health plans, EmblemHealth increased its Medicare Star rating for the second consecutive year. NEW YORK, Oct. 14, 2025 (GLOBE NEWSWIRE [...]
Oral GLP-1 Tablets Gain Momentum as Telehealth Platform MEDVi Expands Access to Compounded Semaglutide and Tirzepatide for Physician-Supervised Weight Management
14/10/2025
Needle-Free Compounded Semaglutide and Tirzepatide Tablets Offer Physician-Supervised, At-Home GLP-1 Treatment Access Through MEDVi’s Nationwide Telehealth Platform Los Angeles, Oct. 14, 2025 (GLOBE NEWSWIRE) -- [...]
Inventiva annonce la mise en place d’un nouveau programme « At-The-Market » (ATM)
14/10/2025
Daix (France), New York City (New York, Etats-Unis), le 14 octobre 2025 – Inventiva (Euronext Paris et Nasdaq : IVA) (« Inventiva » ou la « Société »), société biopharmaceutique spécialisée dans le développement de [...]
Inventiva Announces the Implementation of a New ATM Program
14/10/2025
Daix (France), New York City (New York, United States), October 14, 2025 – Inventiva (Euronext Paris and Nasdaq : IVA) (“ Inventiva ” or the “ Company ”), a clinical-stage biopharmaceutical company focused on the [...]
EyePoint Announces Pivotal Phase 3 Program Initiation for DURAVYU™ in Diabetic Macular Edema
14/10/2025
– DURAVYU now in Phase 3 for the two largest, multi-billion-dollar retinal disease markets, wet AMD and DME with first patient dosing in pivotal Phase 3 DME trials anticipated in Q1 2026 – – New preclinical data [...]
Century Therapeutics to Present at Chardan’s 9th Annual Genetic Medicines Conference
14/10/2025
PHILADELPHIA, Oct. 14, 2025 (GLOBE NEWSWIRE) -- Century Therapeutics, Inc. (‘Century’, NASDAQ: IPSC), a biotechnology company developing induced pluripotent stem cell (iPSC)-derived cell therapies for autoimmune [...]
Alignment Health Plan and Intermountain Health Launch $0-Premium, 5-star Medicare Advantage Plan for Nevada Seniors
14/10/2025
New co-branded HMO expands access to high-quality, affordable care in Clark County, adding second 5-star plan for Alignment in the state LAS VEGAS, Oct. 14, 2025 (GLOBE NEWSWIRE) -- Alignment Health Plan , an award- [...]
GUERBET : Nombre d'actions et de droits de vote composant le capital de la société au 30 septembre 2025
14/10/2025
GUERBET : Nombre d'actions et de droits de vote composant le capital de la société au 30 septembre 2025 En application de l'article L. 233-8 II du code de commerce et de l'article 222-12-5 du règlement général de l'AMF [...]
New Peer-Reviewed Study Shows Cylinder’s Digital Digestive Health Program Improves Outcomes for Socially Vulnerable Populations
14/10/2025
CHICAGO, Oct. 14, 2025 (GLOBE NEWSWIRE) -- Cylinder , the leading virtual digestive health provider, today announced results from a new peer-reviewed study published in JMIR Formative Research , which showed that 86% of [...]
Sequana Medical alfapump® System Highlighted at SIR EDGE 2025 Conference
14/10/2025
Ghent, Belgium , Oct. 14, 2025 (GLOBE NEWSWIRE) -- Sequana Medical NV (Euronext Brussels: SEQUA (the “Company” or “Sequana Medical” ), a pioneer in the treatment of drug-resistant fluid overload in liver disease, heart [...]
Turn Therapeutics Appoints Arthur Golden to Board of Directors
14/10/2025
Veteran corporate advisor to strengthen governance, oversight, and strategic execution as the Company advances late-stage programs WESTLAKE VILLAGE, Calif., Oct. 14, 2025 (GLOBE NEWSWIRE) -- Turn Therapeutics (“Turn” or [...]
Sanofi: Informations relatives au nombre de droits de vote et d'actions - Septembre 2025
14/10/2025
Informations relatives au nombre total de droits de vote et d’actions prévues par l’article L. 233-8 II du Code de commerce et l’article 223-16 du Règlement général de l’Autorité des Marchés Financiers Sanofi Société [...]
Sanofi: Information concerning the total number of voting rights and shares - September 2025
14/10/2025
Information concerning the total number of voting rights and shares, provided pursuant to article L. 233-8 II of the Code de commerce (the French Commercial Code) and article 223-16 of the Règlement général de l’ [...]
The Global Myeloma Community Mourns the Passing of IMF Co-Founder Dr. Brian G.M. Durie
14/10/2025
LOS ANGELES, Oct. 14, 2025 (GLOBE NEWSWIRE) -- It is with great sadness that the International Myeloma Foundation (IMF) shares the news of the death of Dr. Brian G.M. Durie, co-founder of the organization. A Media [...]
SPINEWAY : Croissance du chiffre d’affaires au 3ème trimestre
14/10/2025
Ecully, le 14 octobre 2025 – 18h30 SPINEWAY Croissance du chiffre d’affaires au 3ème trimestre En milliers d’euros 2025 2024 Variation en % CA 3 ème trimestre 3 045 2 575 + 18% CA 2 ème trimestre 2 745 3 465 - 21% CA 1 [...]
Spineway : Revenue growth in the third quarter
14/10/2025
Ecully, October 14, 2025 – 6:30 p.m. SPINEWAY Revenue growth in the third quarter In thousands of euros 2025 2024 Change as a % Q3 revenue 3,045 2,575 +18% Q2 revenue 2,745 3,465 -21% Q1 revenue 2,828 3,070 -8% 9M [...]
CytoMed makes cash bid for potential acquisition of TC BioPharm Limited’s relevant assets
14/10/2025
SINGAPORE, Oct. 14, 2025 (GLOBE NEWSWIRE) -- CytoMed Therapeutics Limited (NASDAQ: GDTC) (“CytoMed” or “Company”), a Singapore-based clinical stage biopharmaceutical company focused on harnessing its proprietary [...]

Pages